Douglas A. Hoover - Publications

Development and pilot evaluation of a virtual reality simulator for HDR prostate brachytherapy.

Journal: Brachytherapy

Published: October 29, 2025

Investigating Setup Error Differences between Conventional and Ultra-Hypofractionated Whole Pelvis Radiation Therapy: A Secondary Analysis from the HOPE Randomized Clinical Trial.

Journal: Journal of applied clinical medical physics

Published: October 16, 2025

Ultrahypofractionated Versus Conventionally Fractionated Whole-pelvis Radiotherapy in Prostate Cancer: A Randomized Clinical Trial.

Journal: European urology oncology

Published: October 07, 2025

Comparison of Computed Tomography Ventilation Imaging and Hyperpolarized 3He Magnetic Resonance Imaging in Patients With Lung Cancer.

Journal: International journal of radiation oncology, biology, physics

Published: September 27, 2025

Application of alanine and ionization chamber dosimetry with a 3D-printed prostate phantom for quality assurance in high dose rate brachytherapy.

Journal: Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)

Published: July 20, 2025

Evaluation of a commercial deep-learning-based contouring software for CT-based gynecological brachytherapy.

Journal: Brachytherapy

Published: April 01, 2025

Novel low dose rate brachytherapy with focal sparing of neurovascular bundle: Report on the primary outcome from the PRIAPUS trial.

Journal: Brachytherapy

Published: February 06, 2025

Towards U-Net-based intraoperative 2D dose prediction in high dose rate prostate brachytherapy.

Journal: Brachytherapy

Published: September 15, 2024

Incorporation of Functional Lung Imaging Into Radiation Therapy Planning in Patients With Lung Cancer: A Systematic Review and Meta-Analysis.

Journal: International journal of radiation oncology, biology, physics

Published: November 01, 2023

Is Ultrahypofractionated Whole Pelvis Radiation Therapy (WPRT) as Well Tolerated as Conventionally Fractionated WPRT in Patients With Prostate Cancer? Early Results From the HOPE Trial.

Journal: International journal of radiation oncology, biology, physics

Published: September 08, 2023

The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER).

Journal: BMC cancer

Published: December 02, 2022

Validation of a surface-based deformable MRI-3D ultrasound image registration algorithm toward clinical implementation for interstitial prostate brachytherapy.

Journal: Brachytherapy

Published: June 21, 2022